Get the Stockscreener App
0.533
5.84%
0.0294
Pre-market:
.56
0.027
+5.07%
Ainos Inc stock is traded at $0.533, with a volume of 613.87K.
It is up +5.84% in the last 24 hours and down -1.99% over the past month.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
See More
Previous Close:
$0.5036
Open:
$0.49
24h Volume:
613.87K
Relative Volume:
2.65
Market Cap:
$12.41M
Revenue:
$93,700
Net Income/Loss:
$-16.13M
P/E Ratio:
-0.1904
EPS:
-2.8
Net Cash Flow:
$-6.32M
1W Performance:
-9.95%
1M Performance:
-1.99%
6M Performance:
+21.08%
1Y Performance:
-37.28%
1-Day Range:
$0.487
$0.55
1-Week Range:
$0.487
$0.59
52-Week Range:
$0.40
$1.07
Ainos Inc Stock (AIMD) Company Profile
Name
Ainos Inc
Sector
Industry
Phone
858-869-2986
Address
AINOS, INC., SAN DIEGO
Compare AIMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AIMD
Ainos Inc
|
0.533 | 12.41M | 93,700 | -16.13M | -6.32M | -2.80 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Ainos Inc Stock (AIMD) Latest News
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street - Lubbock Avalanche-Journal
Digital Smell Technology Breakthrough: Ainos AI Nose Hits 90% Accuracy, Secures Major Industry Partnerships - Stock Titan
Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25 - The Globe and Mail
Ainos reports first revenue from AI smell technology deployments By Investing.com - Investing.com South Africa
Ainos reports first revenue from AI smell technology deployments - Investing.com Australia
Ainos provides mid-year update outlining milestones - TipRanks
Ainos announces 2H25 execution roadmap - TipRanks
Ainos Transforms Smell into Digital Data: 412% Revenue Surge as AI Nose Tech Deploys in Japan - Stock Titan
Ainos (OTCMKTS:AIMD) Shares Up 0.9% – Time to Buy? - Defense World
AI Nose Achieves 85% Accuracy in Elderly Care Monitoring, Targets $29.8B Market | AIMDW Stock News - Stock Titan
Ainos, Inc. (NASDAQ:AIMD) Short Interest Update - Defense World
Ainos announces data on AI Nose in hygiene monitoring - TipRanks
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80% - ACCESS Newswire
Revolutionary AI Nose Technology Hits 85% Accuracy, Targets $76.5B SmellTech Market for Eldercare Crisis - Stock Titan
Ainos showcases AI Nose technology at COMPUTEX 2025 - TipRanks
Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner - PharmiWeb.com
Revolutionary AI Nose Gives Robots Sense of Smell: $76B Market Opportunity Unveiled at COMPUTEX - Stock Titan
Ainos reports interim results in VELDONA trial for FCGS - TipRanks
Revolutionary Cat Dental Treatment Achieves Steroid-Free Remission: Clinical Trial Results Revealed - Stock Titan
Ainos Reports Massive 412% Revenue Surge: AI-Powered Scent Technology Breakthrough Targets $50B Market - Stock Titan
Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors - The Globe and Mail
Ainos (OTCMKTS:AIMD) Shares Down 1.8% – Should You Sell? - Defense World
Ainos, Inc. Reports Significant Revenue Growth in Q1 2025 - TipRanks
Ainos Reports First Quarter 2025 Financial Results - Stock Titan
Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - standard-journal.com
AIMDAinos Inc Latest Stock News & Market Updates - Stock Titan
Revolutionary AI Smell Detection System Enters Semiconductor Manufacturing Through ASE Partnership - Stock Titan
Ainos introduces breath sensing equipment to robots in Japan - Mugglehead Magazine
Revolutionary AI Smell Technology Powers Humanoid Robots in $40B Service Robot Market - Stock Titan
Ainos, Inc: Ugo Robotics Partnership Moving Rapidly with AI Nose Installed - Smartkarma
Ainos (OTCMKTS:AIMD) Stock Price Down 2% – Time to Sell? - Defense World
Ainos partners with ugo to launch smell-sensing robot By Investing.com - Investing.com Canada
Ainos, ugo complete first robotic smell integration in Japan - TipRanks
Ainos and ugo Complete First Robotic Smell Integration in Japan - PharmiWeb.com
Ainos partners with ugo to launch smell-sensing robot - Investing.com Australia
Press Release Distribution & PR Platform - ACCESS Newswire
Revolutionary Breakthrough: AI Robot Now Smells Like HumansSee How This Changes Everything - Stock Titan
Ainos And Ugo Complete First Robotic Smell Integration In Japan - Barchart.com
Ainos secures TFDA approval, IRB clearance to advance VELDONA trials - TipRanks
Major Breakthrough: Ainos Secures Two Key Approvals for $3.3B Market Drug Trials - Stock Titan
Groundbreaking AI Smell Technology Achieves 90% Accuracy, Targets Robotics Revolution - Stock Titan
Ainos Inc Stock (AIMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):